Tarsus Pharmaceuticals (TARS) Stock Chart & Stock Price History $47.84 -0.88 (-1.81%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$47.86 +0.02 (+0.05%) As of 02/21/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Tarsus Pharmaceuticals Stock Price Performance 5 Day Performance-4.74%1 Month Performance-0.56%3 Month Performance-0.83%6 Month Performance+89.02%Year-To-Date Performance-13.60%1 Year Performance+51.68% Receive TARS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address TARS Stock Chart for Saturday, February, 22, 2025 TARS Chart by TradingView Tarsus Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/21/2025$48.72$47.84-1.81%$50.00$47.11465,364 shs$1.83 billion02/20/2025$49.55$48.72-1.68%$49.63$48.50434,841 shs$1.86 billion02/19/2025$50.85$49.55-2.56%$50.66$49.35435,075 shs$1.89 billion02/18/2025$50.22$50.85+1.25%$51.28$49.72512,163 shs$1.94 billion02/17/2025$50.22$50.22$52.52$50.01315,387 shs$1.92 billion02/14/2025$52.23$50.22-3.85%$52.52$50.01315,387 shs$1.92 billion02/13/2025$52.33$52.23-0.19%$53.22$51.09439,489 shs$2.00 billion02/12/2025$51.22$52.33+2.17%$52.97$50.65460,900 shs$2.00 billion02/11/2025$51.76$51.22-1.04%$52.01$49.86515,071 shs$1.96 billion02/10/2025$52.95$51.76-2.25%$53.56$50.95543,627 shs$1.98 billion Get the Latest News and Ratings for TARS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 02/07/2025$53.32$52.95-0.69%$54.28$51.35620,699 shs$2.02 billion02/06/2025$56.94$53.32-6.36%$56.96$52.57587,257 shs$2.04 billion02/05/2025$54.50$56.94+4.48%$57.28$54.89421,315 shs$2.18 billion02/04/2025$54.14$54.50+0.66%$55.98$54.21310,370 shs$2.08 billion02/03/2025$53.76$54.14+0.71%$56.21$52.08399,751 shs$2.07 billion01/31/2025$51.74$53.76+3.90%$54.53$51.84372,733 shs$2.06 billion01/30/2025$53.07$51.74-2.51%$53.77$51.30509,944 shs$1.98 billion01/29/2025$51.06$53.07+3.94%$53.44$50.30366,904 shs$2.03 billion01/28/2025$51.45$51.06-0.76%$51.67$50.05328,450 shs$1.95 billion01/27/2025$48.78$51.45+5.47%$54.08$48.20712,556 shs$1.97 billion01/24/2025$49.12$48.78-0.69%$50.20$48.08464,371 shs$1.86 billion01/23/2025$48.11$49.12+2.10%$50.02$47.55579,865 shs$1.88 billion01/22/2025$46.74$48.11+2.93%$48.34$46.38458,491 shs$1.84 billion01/21/2025$46.52$46.74+0.47%$48.00$45.72551,225 shs$1.79 billion Related Companies Roivant Sciences Stock Price Chart Ascendis Pharma A/S Stock Price Chart Revolution Medicines Stock Price Chart Blueprint Medicines Stock Price Chart Legend Biotech Stock Price Chart Axsome Therapeutics Stock Price Chart Lantheus Stock Price Chart Telix Pharmaceuticals Limited American Depositary Shares Stock Price Chart BridgeBio Pharma Stock Price Chart Nuvalent Stock Price Chart Receive TARS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TARS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
